AbbVie
ABBV
#25
Rank
C$728.03 B
Marketcap
C$411.99
Share price
1.41%
Change (1 day)
34.87%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

Earnings for AbbVie (ABBV)

Earnings in 2026 (TTM): C$12.16 Billion

According to AbbVie's latest financial reports the company's current earnings are C$64.38 Billion. In 2025 the company made an earning of C$9.21 Billion, an increase over its 2024 earnings that were of C$5.19 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AbbVie from 2011 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) C$12.16 B32.04%
2025 C$9.21 B77.53%
2024 C$5.19 B-40.54%
2023 C$8.73 B-53.62%
2022 C$18.82 B3.76%
2021 C$18.14 B282.25%
2020 C$4.74 B-59.67%
2019 C$11.77 B62.13%
2018 C$7.26 B-32.74%
2017 C$10.79 B-1.99%
2016 C$11.01 B18.65%
2015 C$9.28 B180.5%
2014 C$3.30 B-55.57%
2013 C$7.44 B-6.86%
2012 C$7.99 B56.05%
2011 C$5.12 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
C$9.64 B-20.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$46.93 B 286.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$14.37 B 18.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
C$1.41 B-88.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-C$2.74 Billion-122.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$16.63 B 36.91%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$20.02 B 64.75%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
C$11.02 B-9.31%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
C$1.14 B-90.59%๐Ÿ‡บ๐Ÿ‡ธ USA